Pancreatic Cancer Research

ResearcherUniversity of OxfordActive in the last 2 years

Simone Lanfredini

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3160-5120; OpenAlex author ID A5064655386. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. Co-author DOI 10.7554/elife.92672↗
  2. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes. First author DOI 10.1053/j.gastro.2021.04.044↗
  3. RAS in pancreatic cancer. Co-author DOI 10.1042/bst20170521↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eric E. O’Neill · 3 shared papers, 2019–2024 · strength 0.44
  2. Somnath Mukherjee · 2 shared papers, 2021–2024 · strength 0.28
  3. Simei Go · 1 shared paper, 2024 · strength 0.18
  4. Rachael J. M. Bashford-Rogers · 1 shared paper, 2024 · strength 0.18
  5. Keaton Ian Jones · 1 shared paper, 2024 · strength 0.18
  6. Jennifer P. Morton · 1 shared paper, 2024 · strength 0.18
  7. Shivan Sivakumar · 1 shared paper, 2024 · strength 0.18
  8. Zenobia D’Costa · 1 shared paper, 2021 · strength 0.10
  9. Frances W. Willenbrock · 1 shared paper, 2021 · strength 0.10
  10. Tim Maughan · 1 shared paper, 2021 · strength 0.10
  11. Daniel Llwyd Hughes · 1 shared paper, 2021 · strength 0.10
  12. Michael Eyres · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.